| 000 | 01195 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250516025930.0 | ||
| 264 | 0 | _c20111101 | |
| 008 | 201111s 0 0 eng d | ||
| 022 | _a1873-4286 | ||
| 024 | 7 |
_a10.2174/138161211795222667 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBisso, Andrea | |
| 245 | 0 | 0 |
_ap73 as a pharmaceutical target for cancer therapy. _h[electronic resource] |
| 260 |
_bCurrent pharmaceutical design _c2011 |
||
| 300 |
_a578-90 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 | _aDNA Damage |
| 650 | 0 | 4 |
_aDNA-Binding Proteins _xchemistry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aNuclear Proteins _xchemistry |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 | _aTumor Protein p73 |
| 650 | 0 | 4 |
_aTumor Suppressor Proteins _xchemistry |
| 700 | 1 | _aCollavin, Licio | |
| 700 | 1 | _aDel Sal, Giannino | |
| 773 | 0 |
_tCurrent pharmaceutical design _gvol. 17 _gno. 6 _gp. 578-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/138161211795222667 _zAvailable from publisher's website |
| 999 |
_c20664121 _d20664121 |
||